Delivery Order SPE2DR25D1017-SPE2DR26F9BMN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Brilinta 90 mg tablets (60-count units) with a ceiling value of $1,777.25. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by August 7, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $1,514.37. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $10,406.56. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $7,779.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be fulfilled from the contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $3,983.15. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by October 31, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $61,937.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $3,498.37. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by December 11, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Brilinta 90 mg tablets (60-count units) at a ceiling value of $4,019.96. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The order is scheduled for completion by August 28, 2025, with the place of performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract ceiling value of $1,741.14. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance—is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,154.20 to supply 60-milligram Brilinta tablets in quantities of 60 units. This non-competitive delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The award is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BMNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $1,010.09. This is a firm fixed-price delivery order with an ultimate completion date of December 16, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally, encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The award reflects AmerisourceBergen Drug Corp's established capability as a critical federal pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/14/25 |